abstract |
Naphthyridine compounds and their use as inhibitors of HPK1 are described. The compounds are useful in treating HPK1-dependent disorders and enhancing immune responses. Also described are methods of inhibiting HPK1, methods of treating HPK1-dependent disorders, methods of enhancing an immune response, and methods of preparing naphthyridine compounds. [Selection diagram] None |